Please use this identifier to cite or link to this item: https://repository.sustech.edu/handle/123456789/23571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDaoud, Almaqdad Abdelrahman Aldouma-
dc.contributor.authorMosaad, Amin Mohamed Abdallah-
dc.contributor.authorMahgob, Eatedal Awad Mohamed-
dc.contributor.authorMatar, Hanadi Abdulrahman Alamin-
dc.contributor.authorAli, Shema AbdAlAzeem A.Hadi-
dc.contributor.authorSupervisor, -Sumaia Awad Elkariem Ali Mohammed-
dc.date.accessioned2019-10-21T10:02:10Z-
dc.date.available2019-10-21T10:02:10Z-
dc.date.issued2018-11-06-
dc.identifier.citationDaoud, Almaqdad Abdelrahman Aldouma.Antitrypanosomal Activity of Quinapyramine Sulphate and Diminazene Diaceturate against T. evansi in Experimentally Infected Wistar Albino Rats \ Almaqdad Abdelrahman Aldouma Daoud .... {eatel} ; Sumaia Awad Elkariem Ali Mohammed .- khartoum :Sudan University of Science and Technology ,College of Veterinary Medicine,2018.- 38p. :ill. ;28cm .-Bachelors Searchen_US
dc.identifier.urihttp://repository.sustech.edu/handle/123456789/23571-
dc.descriptionBachelors Searchen_US
dc.description.abstractTrypansoma evansi causes an important disease of camel called Surra which is transmitted mechanically by various tabanids and other flies. Surra causes economic losses from decreased productivity in working animals, reduced weight gain, decreased milk yield, reproductive losses and the cost of treatment. This study aimed to evaluate the efficacy of quinapyramine sulphate compared with diminazene diaceturate in the treatment of T. evansi isolated from camel in Wistar albino rats. Twenty rats were divided into four groups ( I, II, III, & IV), group I was kept as normal control, group II as a positive control, group III as a standard drug control, rats were treated with diminazenediaceturate at a dose of 3.5 mg/kg bw subcutaneously at day 4 of parasitaemia, while group IV was treated with the test drug quinapyraminesulphate at a dose of 3g/600-1000 kg bw subcutaneously at day 4 of parasitaemia. Parasitaemia was investigated daily using wet smear method. The level of parasitaemia in treated groups were compared with uninfected untreated rats. The results indicated that quinapyraminesulphatehas low efficacy against T. evansi compared to diminazenediaceturate used as a standard drug. However the parasitaemia of quinapyraminesulphate group increased significantly (p< 0.05) than the parasitaemia of infected untreated group. Diminazenediaceturate produced significant efficacy which indicated by the sharp clearance of parasite from the blood from day one of treatment till the end of experiment. Infected untreated control rats produced significant decrease(p< 0.05) in Packed Cell Volume (PCV) compared tonormal control and other groups. It is concluded that T. evansi showed high level of resistance againstantitrypanosomal drug; quinapyramine sulphate compared to diminazene diaceturate in rats. Clinical trials are recommended to evaluate the efficacy of quinapyraminesulphate in camel, horses and other livestock.en_US
dc.description.sponsorshipSudan University of Science & Technologyen_US
dc.language.isoenen_US
dc.publisherSudan University of Science and Technologyen_US
dc.subjectVeterinary Medicineen_US
dc.subjectAntitrypanosomal Activityen_US
dc.subjectQuinapyramine Sulphateen_US
dc.subjectDiminazene Diaceturate against T. evansien_US
dc.subjectExperimentally Infected Wistar Albino Ratsen_US
dc.titleAntitrypanosomal Activity of Quinapyramine Sulphate and Diminazene Diaceturate against T. evansi in Experimentally Infected Wistar Albino Ratsen_US
dc.typeThesisen_US
Appears in Collections:Bachelorof Veterinary Medicine

Files in This Item:
File Description SizeFormat 
Antitrypanosomal Activity .....pdfResearch1.82 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.